Validity study of educational technology on gynecological high dose rate (HDR) brachytherapy.
Meiriane Lopes Ximenes, Mariana Alves Firmeza, Andrea Bezerra Rodrigues and 4 others
PMID 37075360WHAT IT FOUND
A booklet for nurses to explain gynecological brachytherapy side effects and care was validated by experts and 27 women.
It scored 98% agreement among judges and was rated clear and attractive by all patients, but its effect on attendance or anxiety is not yet tested.
Key findings
01The educational booklet achieved an overall Content Validity Index of 0.98 in the second round of expert review, meeting the threshold for validity.
02All 27 women who tested the booklet in clinical validity considered it clear and attractive, with 81.4% rating it very relevant.
03The booklet was designed to support nurses in outpatient consultations by addressing side effects like diarrhea, lymphedema, and vaginal stenosis, and emphasizing treatment attendance.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study validates the booklet's content and acceptability, not its clinical effectiveness on outcomes like anxiety or attendance. There was a loss of judges between the first and second Delphi rounds (11 to 9). The clinical validity sample was small (27 women) and from a single center. Participants were literate and cognitively able (MMSE screened), so findings may not apply to women with low literacy or cognitive impairment.
Declared interests
No specific funding source or conflict of interest declaration is provided in the text, other than the study being part of a larger project at a public institution.
The easy way to misread this
Do not assume the booklet improves patient outcomes like anxiety or treatment attendance. This study only proves experts and patients found the content valid and acceptable; the randomized trial testing its effectiveness is still underway.